Ipix is very fortunate to have the RBLs advancing Brilacidin for them. But getting the news out is taking its time and at least this article gets some exposure for Ipix. Because I believe it’s truly reflective of Ipix’s current state I don’t see it as a pump. If I didn’t believe Ipix I would think otherwise.